Creative Planning Mirum Pharmaceuticals, Inc. Transaction History
Creative Planning
- $103 Billion
- Q4 2024
A detailed history of Creative Planning transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Creative Planning holds 8,130 shares of MIRM stock, worth $406,825. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,130
Previous 6,382
27.39%
Holding current value
$406,825
Previous $248,000
35.48%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
208Shares Held
54MCall Options Held
64.1KPut Options Held
117K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$329 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$229 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$162 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$140 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$130 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.84B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...